A detailed history of Argent Financial Group, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Argent Financial Group, Inc. holds 8,163 shares of BMY stock, worth $477,535. This represents 0.05% of its overall portfolio holdings.

Number of Shares
8,163
Holding current value
$477,535
% of portfolio
0.05%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$39.66 - $51.75 $323,744 - $422,435
8,163 New
8,163 $422 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Argent Financial Group, Inc. Portfolio

Follow Argent Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Argent Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Argent Financial Group, Inc. with notifications on news.